<DOC>
	<DOCNO>NCT02359890</DOCNO>
	<brief_summary>This prospective safety assessment study device radiofrequency ( RF ) ablation treatment patient drug refractory symptomatic atrial fibrillation ( SMART-SF ) .</brief_summary>
	<brief_title>SMART-SF Radiofrequency Ablation Safety Study</brief_title>
	<detailed_description>The purpose study demonstrate safety study device treatment drug refractory symptomatic paroxysmal atrial fibrillation ( PAF ) standard electrophysiology map RF ablation procedure .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Symptomatic paroxysmal atrial fibrillation ( AF ) least one AF episode electrocardiographically document within one ( 1 ) year prior enrollment physician 's note indicating recurrent , selfterminating AF . Electrocardiographic documentation may include , limited , electrocardiogram ( ECG ) , transtelephonic monitor ( TTM ) , Holter monitor ( HM ) , telemetry strip Failed least one antiarrhythmic drug ( AAD ) ( class I III , atrioventricular ( AV ) nodal block agent beta blocker calcium channel blocker ) evidence recurrent symptomatic AF , intolerable AAD Age 18 year old Atrial fibrillation secondary electrolyte imbalance , thyroid disease , reversible noncardiac cause Previous surgical catheter ablation atrial fibrillation Amiodarone time past 3 month Any percutaneous coronary intervention ( PCI ) , cardiac surgery , valvular cardiac surgical percutaneous procedure ( e.g. , ventriculotomy , atriotomy , valve repair replacement presence prosthetic valve ) within past 2 month Any carotid stenting endarterectomy Coronary artery bypass graft ( CABG ) surgery within past 6 month AF episodes lasting &gt; 7 day Documented left atrial ( LA ) thrombus image LA size &gt; 50 mm Left ventricular ejection fraction ( LVEF ) &lt; 40 % Contraindication anticoagulation ( heparin warfarin ) History blood clot bleed abnormality MI within past 2 month Documented thromboembolic event ( include transient ischemic attack ( TIA ) ) within past 12 month Rheumatic Heart Disease Uncontrolled heart failure New York Heart Association ( NYHA ) function class III IV Awaiting cardiac transplantation cardiac surgery within next 12 month Unstable angina Acute illness active systemic infection sepsis Diagnosed atrial myxoma Presence implant implantable cardioverter defibrillator ( ICD ) Significant pulmonary disease , ( eg , restrictive pulmonary disease , constrictive chronic obstructive pulmonary disease ) disease malfunction lungs respiratory system produce chronic symptom Significant congenital anomaly medical problem opinion investigator would preclude enrollment study Women pregnant ( evidenced pregnancy test premenopausal ) Enrollment investigational study evaluate another device , biologic , drug Presence intramural thrombus , tumor abnormality precludes vascular access , manipulation catheter Presence condition precludes vascular access Life expectancy disease process likely limit survival le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Interventional</keyword>
	<keyword>Radiofrequency ablation</keyword>
	<keyword>Paroxysmal Atrial Fibrillation</keyword>
</DOC>